" /> Cerebral creatine deficiency syndrome 3 - CISMeF





Preferred Label : Cerebral creatine deficiency syndrome 3;

Symbol : CCDS3;

CISMeF acronym : CCDS3;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Gatm deficiency; Agat deficiency; Arginine:glycine amidinotransferase deficiency; Creatine deficiency syndrome due to agat deficiency;

Description : Cerebral creatine deficiency syndrome-3 is an autosomal recessive disorder characterized by developmental delay/regression, mental retardation, severe disturbance of expressive and cognitive speech, and severe depletion of creatine/phosphocreatine in the brain (Schulze, 2003). Most patients develop a myopathy characterized by muscle weakness and atrophy later in life. Oral creatine supplementation can offer symptom improvement (summary by Edvardson et al., 2010). For a general phenotypic description and a discussion of genetic heterogeneity of cerebral creatine deficiency syndrome, see CCDS1 (300352).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the L-arginine:glycine amidinotransferase gene (GATM, 602360.0001);

Laboratory abnormalities : Organic aciduria; Decreased plasma and urinary guanidinoacetate (GAA);

Prefixed ID : #612718;

Details


You can consult :


Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.